Biotechnology; Pharmaceutical; Therapeutics
Promethera Biosciences has raised €47M across 2 funding rounds from 7 investors, most recently a Series D+ round in Oct 2019. Based in Mont-Saint-Guibert, Belgium; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2019-10-01 | Series D+ | €7.5M | Sony Innovation Fund | View deal → |
| 2019-04-01 | Series D+ | €40M | Ci:z Investment LLP,ITOCHU Corporation,Korea Investment Partners,Mirae Asset Capital,Mitsui & Co.,Shinsei Capital Partners | View deal → |
